ClinicalTrials.gg
CompletedNCT05661136Updated Feb 14, 2025

Maternal Postop Temperature After Cesarean Delivery

An interventional study of Warm air blower and Control: Lower body blanket not attached to warm air blower in Temperature Change, Body, Cesarean Delivery and Spinal Anesthesia, sponsored by Tel-Aviv Sourasky Medical Center. Completed at 1 site in Israel. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-02-14.

Sponsored by Tel-Aviv Sourasky Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

It is unclear whether routine addition of intra-operative forced-air warming in addition to warmed intravenous fluids during cesarean delivery under spinal anesthesia is beneficial. In this single-center randomized trial, we aim to test the primary null hypothesis that our current protocol of warmed intravenous fluids is similar to a combination of warmed intravenous fluids with intra-operative lower-body forced-air warming to maintain maternal temperature after cesarean delivery under spinal anesthesia.

We also aim to assess the rate of maternal shivering during and after the procedure between the two groups, the maternal thermal comfort score, neonatal Apgar scores and umbilical pH levels. If we demonstrate no clinically important difference between the two interventions, clinicians will be able to continue our current protocol of warmed intravenous fluids only during cesarean delivery.

Read the detailed description

Primary aim Investigate whether a combination of intra-operative lower-body forced-air warming and warmed IV fluids is superior to our current standard of warmed IV fluids alone in influencing maternal core temperature following spinal anesthesia for cesarean delivery.

Secondary aim

  1. To compare mean core temperature on arrival to post-anesthesia care unit (PACU) in women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
  2. To compare incidence of hypothermia among women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
  3. To compare incidence of shivering following recovery in post anesthesia care unit (PACU) in women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
  4. To compare thermal comfort levels for women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
  5. To compare use of meperidine in post anesthesia care unit (PACU) to treat postoperative shivering, in women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
  6. To compare newborn outcomes (rectal temperature at birth, umbilical vein pH \& Apgar scores post-delivery) in women who received combination of intra-operative lower-body forced-air warming and warmed IV fluids versus IV fluids alone
02

Conditions studied

  • Temperature Change, Body
  • Cesarean Delivery
  • Spinal Anesthesia
03

In context

Body Temperature Changes

97 studies on the registry are indexed under Body Temperature Changes; 20 are open to participants now.

This study's enrollment of 66 is above the median of 40 across 68 interventional studies indexed under Body Temperature Changes.

Browse Body Temperature Changes studies →

Lead sponsor

Tel-Aviv Sourasky Medical Center is the lead sponsor of 554 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Written
  2. Age between 18-50 years old
  3. (ASA) physical status 2-3
  4. Gestational age greater than 37 completed weeks
  5. Singleton pregnancy
  6. Elective cesarean delivery.

Exclusion criteria

Exclusion Criteria:

  1. Known allergy to local anesthetics
  2. for spinal anesthesia

    1. Patient refusal
    2. Bleeding diathesis
    3. Neuropathy
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
66 participants (actual)

Study arms

  • Experimental
    Warm air blower

    Intra-operative lower-body forced-air warming after spinal anesthesia and co-loading 1000 mL liters of IV warmed-fluids started prior to performing spinal anesthesia

    Device: Warm air blower

  • Active comparator
    Control

    Co-loading of 1000 mL liters of IV warmed-fluids started prior to performing spinal anesthesia

    Other: Control: Lower body blanket not attached to warm air blower

Interventions

  • DeviceWarm air blower

    Lower body blanket with warm air blower set at 44 deg c started after spinal anesthesia when patient placed in supine/left lat position

  • OtherControl: Lower body blanket not attached to warm air blower

    Control: Lower body blanket placed, not attached to warm air blower

06

What researchers measure

Primary outcomes

  1. The mean core temperature

    The primary aim is the mean core temperature on arrival to PACU. The means for the two groups will be compared.

    Time frame: baseline, immediately before spinal anesthesia, 60 minutes following spinal anesthesia and then every 30 minutes for 2 hours (last measurement prior to discharge)

Secondary outcomes

  1. Maternal hypothermia

    Maternal hypothermia yes/no defined as core body temperature \<36°C

    Time frame: 60 minutes following spinal anesthesia

  2. Shivering

    Shivering score - 0 - no shivering 1. - One or more of the following: piloerection, peripheral vasoconstriction, peripheral cyanosis without other cause, but without visible muscular activity 2. - Visible muscular activity confined to one muscle group 3. - Visible muscular activity in more than one muscle group 4. - Gross muscular activity involving the whole body

    Time frame: Postoperative - every 30 minutes for 2 hours (last measurement prior to discharge)

  3. Maternal thermal comfort

    Maternal thermal comfort scores (• Thermal comfort scale - a 0 to 10 scale will be used with the descriptors to a single question - "How warm or cold are you? o "Worst imaginable cold", " thermally neutral, " and " insufferably hot " representing the 0, 5, and 10 of the scale, respectively) will be obtained at baseline, 30 minutes during surgery, and on admission to PACU

    Time frame: baseline, immediately before spinal anesthesia , 60 minutes following spinal anesthesia, and then every 30 minutes for 2 hours (last measurement prior to discharge)

  4. Meperidine

    Meperidine administration (timing and dose) used to treat shivering

    Time frame: Postoperative - up to two hours during PACU recovery after the procedure

  5. Apgar

    Apgar scores (at 1 and 5 minutes) will be determined by the pediatrician (not involved in the study)

    Time frame: 1 and 5 minutes after newborn delivery

  6. Newborn Temperature

    Newborn rectal temperature

    Time frame: Upon newborn's arrival to newborn ward - approximately 30 minutes following delivery

  7. Umbilical vein pH

    venous blood gases will be obtained for analysis from a double-clamped segment of umbilical cord

    Time frame: Immediately following placenta removal intraoperatively

07

Study locations

1 site
  • Tel Aviv SMO
    Tel Aviv, Israel
08

References and documents

Individual participant data

Plan to share: No — no plan

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2022 to primary completion in Mar 2023, 2 months.

Of 44 non-industry interventional studies with no phase under Body Temperature Changes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 2 months is below that.

Counting every sponsor, half of 44 studies reached it within 5 months; a quarter within 3 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 6, 2022
First posted
Dec 22, 2022
StartActual
Dec 13, 2022
Primary completionActual
Mar 8, 2023
CompletionActual
Mar 9, 2023
Last update
Feb 14, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05661136
Responsible party
Sponsor
First posted
Dec 22, 2022
Start date
Dec 13, 2022
Primary completion
Mar 8, 2023
Completion
Mar 9, 2023
Last update
Feb 14, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion